Results 31 to 40 of about 19,480 (219)

Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter α/β to reduce bile acids reabsorption

open access: yesCurrent Research in Pharmacology and Drug Discovery, 2023
The high levels of bile acids are a critical factor in hepatorenal syndrome. Organic solute transporter α/β (Ostα/β) participate in bile acids reabsorption in the kidney.
Xiaojuan Zhao   +6 more
doaj   +1 more source

Intrarenal Resistance Index as a Prognostic Parameter in Patients with Liver Cirrhosis Compared with Other Hepatic Scoring Systems [PDF]

open access: yes, 2012
Background and Aims: Patients with advanced liver cirrhosis who develop renal dysfunction have a poor prognosis. Elevated intrarenal resistance indices (RIs) due to renal vascular constriction have been described before in cirrhotic patients.
Bardi A   +14 more
core   +1 more source

Beta-blokers in patients with cirrhosis and infection: don't blame too soon. [PDF]

open access: yes, 2015
We found that PPI-users had a higher rate and BBs-users a lower rate of infections. The lower infection rate and better prognosis of BB-users can not be attributed, as suggested by Schiavon et al., to a higher proportion of variceal bleeding in this ...
LUCIDI, CRISTINA   +3 more
core   +1 more source

Vasoconstrictors in hepatorenal syndrome – A critical review

open access: yesAnnals of Hepatology, 2019
Hepatorenal syndrome has the worst prognosis among causes of acute kidney injury in cirrhotic patients. Its definitive treatment is liver transplantation.
Ângelo Z. Mattos   +2 more
doaj   +1 more source

Hepatorenal Syndrome in the Emergency Department: A Case Report

open access: yesInternational Journal of Medical Students, 2014
Background: Hepatorenal syndrome is a condition where there is functional renal failure in a background of liver disease. It is relatively common in patients with liver cirrhosis and is associated with a high mortality rate if untreated.
Win Jim Tan, Mohan Tiruchittampalam
doaj   +1 more source

Terlipressin in combination with albumin as a therapy for hepatorenal syndrome in patients aged 65 years or older

open access: yesAnnals of Hepatology, 2023
Introduction and Objectives: Clinical data for older patients with advanced liver disease are limited. This post hoc analysis evaluated the efficacy and safety of terlipressin in patients aged ≥65 years with hepatorenal syndrome using data from 3 Phase ...
Muhammad A. Mujtaba   +8 more
doaj   +1 more source

HEPATORENAL SYNDROME: DIAGNOSTIC AND THERAPEUTIC MANAGEMENT

open access: yesAlʹmanah Kliničeskoj Mediciny, 2016
The practical guidelines on diagnosis and management of hepatorenal syndrome, which could be useful for general medical practitioners, gastroenterologists, and hepatologists, are considered in this paper.
I. G. Bakulin, A. A. Varlamicheva
doaj   +1 more source

Prognosis of Acute Kidney Injury and Hepatorenal Syndrome in Patients with Cirrhosis: A Prospective Cohort Study

open access: yesInternational Journal of Nephrology, 2015
Background/Aims. Acute kidney injury is a common problem for patients with cirrhosis and is associated with poor survival. We aimed to examine the association between type of acute kidney injury and 90-day mortality. Methods.
Andrew S. Allegretti   +9 more
doaj   +1 more source

Recovery from Hepatorenal Syndrome after Orthotopic Liver Transplantation [PDF]

open access: yes, 1973
Three patients with progressive renal failure and advanced hepatic insufficiency due to cirrhosis of the liver underwent orthotopic liver transplantation.
Berk   +9 more
core   +1 more source

Predictive factors of neurological complications and one-month mortality after liver transplantation. [PDF]

open access: yes, 2014
BackgroundNeurological complications are common after orthotopic liver transplantation (OLT). We aimed to characterize the risk factors associated with neurological complications and mortality among patients who underwent OLT in the post-model for end ...
Akhtar, Shahrzad   +6 more
core   +1 more source

Home - About - Disclaimer - Privacy